An in-vitro model for tumor immunotherapy with antibody heteroconjugates.
Jung
G
G
Eberhard
H J
HJ
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000945:Antigens, Differentiation, T-Lymphocyte / Q000276:immunology*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017252:CD3 Complex; D006801:Humans; D051379:Mice; D011948:Receptors, Antigen, T-Cell / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D014407:Tumor Cells, Cultured / Q000276:immunology*
D000911:Antibodies, Monoclonal; D000945:Antigens, Differentiation, T-Lymphocyte; D000970:Antineoplastic Agents; D017252:CD3 Complex; D011948:Receptors, Antigen, T-Cell